ALEGLITAAR. A NEW. POTENT, AND BALANCED DUAL PPARA/G AGONIST FOR THE TREATMENT OF TYPE II DIABETES
PDB id Source Resolution
3G9E 2.3 angstroms
Ligand Information
Ligand Validity Binding
Data		 Ligand
Warnings		 Eolus Viewer
(click picture
to launch)		 Chemaxon
Viewer		 Molecular
Weight
(Da)		 Formula SMILES
RO7 Valid ic50 =  0.019 uM   launch gocavviewer-lite   437.508
C24 H23 N O5 S
 Cc1c(nc(o1)c2ccccc2)CCOc3ccc(c4c3ccs4)C[C@@H](C(=O)O)OC

ALEGLITAZAR, A NEW, POTENT, AND BALANCED DUAL PPARALPHA/GAMMA AGONIST FOR THE TREATMENT OF TYPE II DIABETES. BIOORG.MED.CHEM.LETT. V. 19 2468 2009

More Information
External References
PDB
Pubmed
Biounit Downloads
This PDB
This Family
This Class
Comma Separated Files
This PDB
This Family
This Class
Download BindingMOAD
90% Homology Family

The Class containing this family consists of a total of 26 families.
Leader:    3FEJ
DESIGN AND BIOLOGICAL EVALUATION OF NOVEL, BALANCED
DUAL PPARA/G AGONISTS
PDB id Binding data Representative ligand
3FEJ Ki = 0.74 uM CTM
2FVJ   RO0
3G9E ic50 = 0.019 uM RO7